Literature DB >> 17680557

Body mass index and risk of multiple myeloma: a meta-analysis.

Susanna C Larsson1, Alicja Wolk.   

Abstract

Excess body weight has been identified as a risk factor for a variety of cancer types. However, whether excess body weight increases the risk of multiple myeloma remains controversial. We conducted a meta-analysis to quantitatively summarize the evidence from epidemiologic studies of the associations of overweight and obesity with the risk of multiple myeloma. We searched the MEDLINE and EMBASE databases (1966 to May 2007) and the reference lists of retrieved articles. Cohort and case-control studies were included if they reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the relation between body mass index and multiple myeloma incidence or mortality. A random-effects model was used to combine study-specific results. A total of 11 cohort studies (involving 13,120 cases) and 4 case-control studies (1,166 cases and 8,247 controls) were included in the meta-analysis. Compared with individuals with normal weight, the risk of multiple myeloma was statistically significantly higher among those who were overweight (cohort studies: RR, 1.12, 95% CI, 1.07-1.18; case-control studies: RR, 1.43; 95% CI, 1.23-1.68) or obese (cohort studies: RR, 1.27, 95% CI, 1.15-1.41; case- control studies: RR, 1.82, 95% CI, 1.47-2.26). Results from this meta-analysis indicate that excess body weight may be a risk factor for multiple myeloma. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17680557     DOI: 10.1002/ijc.22968

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Obesity, weight gain, and risk of chronic myeloid leukemia.

Authors:  Sara S Strom; Yuko Yamamura; Hagop M Kantarijian; Jorge E Cortes-Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

2.  Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study.

Authors:  Marianna Thordardottir; Ebba K Lindqvist; Sigrun H Lund; Rene Costello; Debra Burton; Neha Korde; Sham Mailankody; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Tamara B Harris; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-01

3.  Obesity and neoplasms of lymphohematopoietic cells.

Authors:  Marshall A Lichtman
Journal:  Blood Adv       Date:  2016-11-22

4.  Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).

Authors:  Brenda M Birmann; Gabriella Andreotti; Anneclaire J De Roos; Nicola J Camp; Brian C H Chiu; John J Spinelli; Nikolaus Becker; Véronique Benhaim-Luzon; Parveen Bhatti; Paolo Boffetta; Paul Brennan; Elizabeth E Brown; Pierluigi Cocco; Laura Costas; Wendy Cozen; Silvia de Sanjosé; Lenka Foretová; Graham G Giles; Marc Maynadié; Kirsten Moysich; Alexandra Nieters; Anthony Staines; Guido Tricot; Dennis Weisenburger; Yawei Zhang; Dalsu Baris; Mark P Purdue
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-21       Impact factor: 4.254

5.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

Review 6.  Metabolic syndrome and cancer.

Authors:  Pooja Pothiwala; Sushil K Jain; Subhashini Yaturu
Journal:  Metab Syndr Relat Disord       Date:  2009-08       Impact factor: 1.894

7.  Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.

Authors:  Brenda M Birmann; Marian L Neuhouser; Bernard Rosner; Demetrius Albanes; Julie E Buring; Graham G Giles; Qing Lan; I-Min Lee; Mark P Purdue; Nathaniel Rothman; Gianluca Severi; Jian-Min Yuan; Kenneth C Anderson; Michael Pollak; Nader Rifai; Patricia Hartge; Ola Landgren; Lawrence Lessin; Jarmo Virtamo; Robert B Wallace; JoAnn E Manson; Graham A Colditz
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

Review 8.  The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review.

Authors:  Matthias Lenz; Tanja Richter; Ingrid Mühlhauser
Journal:  Dtsch Arztebl Int       Date:  2009-10-02       Impact factor: 5.594

9.  Multiple Myeloma Mortality in Relation to Obesity Among African Americans.

Authors:  Jennifer S Sonderman; Traci N Bethea; Cari M Kitahara; Alpa V Patel; Chinonye Harvey; Synnøve F Knutsen; Yikyung Park; Song-Yi Park; Gary E Fraser; Lauren R Teras; Mark P Purdue; Rachael Z Stolzenberg-Solomon; Elizabeth M Gillanders; Julie R Palmer; Laurence N Kolonel; William J Blot
Journal:  J Natl Cancer Inst       Date:  2016-05-04       Impact factor: 13.506

10.  Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019.

Authors:  Linghui Zhou; Qin Yu; Guoqing Wei; Linqin Wang; Yue Huang; Kejia Hu; Yongxian Hu; He Huang
Journal:  BMC Cancer       Date:  2021-05-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.